Lucid Diagnostics Stock Technical Analysis
| LUCD Stock | USD 1.36 0.02 1.45% |
As of the 22nd of February, Lucid Diagnostics secures the Risk Adjusted Performance of 0.0993, downside deviation of 3.18, and Mean Deviation of 2.69. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Lucid Diagnostics, as well as the relationship between them. Please verify Lucid Diagnostics coefficient of variation, maximum drawdown, skewness, as well as the relationship between the information ratio and downside variance to decide if Lucid Diagnostics is priced some-what accurately, providing market reflects its recent price of 1.36 per share. Given that Lucid Diagnostics is a hitting penny stock territory we strongly suggest to closely look at its total risk alpha.
Lucid Diagnostics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Lucid, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to LucidLucid Diagnostics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Lucid Diagnostics Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 3.79 | Strong Buy | 6 | Odds |
Most Lucid analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Lucid stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Lucid Diagnostics, talking to its executives and customers, or listening to Lucid conference calls.
Will Health Care Equipment & Supplies sector continue expanding? Could Lucid diversify its offerings? Factors like these will boost the valuation of Lucid Diagnostics. Expected growth trajectory for Lucid significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Lucid Diagnostics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.77) | Revenue Per Share | Quarterly Revenue Growth 0.033 | Return On Assets | Return On Equity |
Understanding Lucid Diagnostics requires distinguishing between market price and book value, where the latter reflects Lucid's accounting equity. The concept of intrinsic value - what Lucid Diagnostics' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Lucid Diagnostics' price substantially above or below its fundamental value.
Understanding that Lucid Diagnostics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Lucid Diagnostics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Lucid Diagnostics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Lucid Diagnostics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lucid Diagnostics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lucid Diagnostics.
| 11/24/2025 |
| 02/22/2026 |
If you would invest 0.00 in Lucid Diagnostics on November 24, 2025 and sell it all today you would earn a total of 0.00 from holding Lucid Diagnostics or generate 0.0% return on investment in Lucid Diagnostics over 90 days. Lucid Diagnostics is related to or competes with Rapid Micro, Apyx Medical, Avita Medical, Opus Genetics, Sharps Technology, Anteris Technologies, and Seer. Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company More
Lucid Diagnostics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lucid Diagnostics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lucid Diagnostics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.18 | |||
| Information Ratio | 0.0972 | |||
| Maximum Drawdown | 18.0 | |||
| Value At Risk | (4.72) | |||
| Potential Upside | 6.09 |
Lucid Diagnostics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lucid Diagnostics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lucid Diagnostics' standard deviation. In reality, there are many statistical measures that can use Lucid Diagnostics historical prices to predict the future Lucid Diagnostics' volatility.| Risk Adjusted Performance | 0.0993 | |||
| Jensen Alpha | 0.386 | |||
| Total Risk Alpha | 0.0872 | |||
| Sortino Ratio | 0.1081 | |||
| Treynor Ratio | 1.03 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Lucid Diagnostics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Lucid Diagnostics February 22, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0993 | |||
| Market Risk Adjusted Performance | 1.04 | |||
| Mean Deviation | 2.69 | |||
| Semi Deviation | 2.66 | |||
| Downside Deviation | 3.18 | |||
| Coefficient Of Variation | 833.47 | |||
| Standard Deviation | 3.54 | |||
| Variance | 12.51 | |||
| Information Ratio | 0.0972 | |||
| Jensen Alpha | 0.386 | |||
| Total Risk Alpha | 0.0872 | |||
| Sortino Ratio | 0.1081 | |||
| Treynor Ratio | 1.03 | |||
| Maximum Drawdown | 18.0 | |||
| Value At Risk | (4.72) | |||
| Potential Upside | 6.09 | |||
| Downside Variance | 10.13 | |||
| Semi Variance | 7.09 | |||
| Expected Short fall | (3.38) | |||
| Skewness | 0.8144 | |||
| Kurtosis | 1.66 |
Lucid Diagnostics Backtested Returns
Lucid Diagnostics appears to be very risky, given 3 months investment horizon. Lucid Diagnostics has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Lucid Diagnostics, which you can use to evaluate the volatility of the firm. Please exercise Lucid Diagnostics' Mean Deviation of 2.69, risk adjusted performance of 0.0993, and Downside Deviation of 3.18 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Lucid Diagnostics holds a performance score of 10. The company secures a Beta (Market Risk) of 0.4, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, Lucid Diagnostics' returns are expected to increase less than the market. However, during the bear market, the loss of holding Lucid Diagnostics is expected to be smaller as well. Please check Lucid Diagnostics' maximum drawdown, skewness, and the relationship between the total risk alpha and downside variance , to make a quick decision on whether Lucid Diagnostics' current price movements will revert.
Auto-correlation | 0.45 |
Average predictability
Lucid Diagnostics has average predictability. Overlapping area represents the amount of predictability between Lucid Diagnostics time series from 24th of November 2025 to 8th of January 2026 and 8th of January 2026 to 22nd of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lucid Diagnostics price movement. The serial correlation of 0.45 indicates that just about 45.0% of current Lucid Diagnostics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.45 | |
| Spearman Rank Test | 0.23 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Lucid Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Lucid Diagnostics Technical Analysis
The output start index for this execution was ten with a total number of output elements of fifty-one. The Normalized Average True Range is used to analyze tradable apportunities for Lucid Diagnostics across different markets.
About Lucid Diagnostics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Lucid Diagnostics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Lucid Diagnostics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Lucid Diagnostics price pattern first instead of the macroeconomic environment surrounding Lucid Diagnostics. By analyzing Lucid Diagnostics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Lucid Diagnostics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Lucid Diagnostics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 7.4 | 6.66 | 5.99 | 3.58 | Days Of Inventory On Hand | 11.97 | 15.06 | 17.32 | 16.45 |
Lucid Diagnostics February 22, 2026 Technical Indicators
Most technical analysis of Lucid help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Lucid from various momentum indicators to cycle indicators. When you analyze Lucid charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0993 | |||
| Market Risk Adjusted Performance | 1.04 | |||
| Mean Deviation | 2.69 | |||
| Semi Deviation | 2.66 | |||
| Downside Deviation | 3.18 | |||
| Coefficient Of Variation | 833.47 | |||
| Standard Deviation | 3.54 | |||
| Variance | 12.51 | |||
| Information Ratio | 0.0972 | |||
| Jensen Alpha | 0.386 | |||
| Total Risk Alpha | 0.0872 | |||
| Sortino Ratio | 0.1081 | |||
| Treynor Ratio | 1.03 | |||
| Maximum Drawdown | 18.0 | |||
| Value At Risk | (4.72) | |||
| Potential Upside | 6.09 | |||
| Downside Variance | 10.13 | |||
| Semi Variance | 7.09 | |||
| Expected Short fall | (3.38) | |||
| Skewness | 0.8144 | |||
| Kurtosis | 1.66 |
Lucid Diagnostics February 22, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Lucid stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | (0.50) | ||
| Rate Of Daily Change | 0.99 | ||
| Day Median Price | 1.38 | ||
| Day Typical Price | 1.37 | ||
| Price Action Indicator | (0.03) | ||
| Market Facilitation Index | 0.04 |
Complementary Tools for Lucid Stock analysis
When running Lucid Diagnostics' price analysis, check to measure Lucid Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lucid Diagnostics is operating at the current time. Most of Lucid Diagnostics' value examination focuses on studying past and present price action to predict the probability of Lucid Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lucid Diagnostics' price. Additionally, you may evaluate how the addition of Lucid Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |